KACTUS

Biotechnology Research • Waltham, Massachusetts, United States • 21-50 Employees

Company overview

Headquarters	60 Hickory Dr, Waltham, Massachusetts 02451, US
Phone number	+16176657333
Websites	kactusbio.com kactusbio.us
NAICS	541714
Keywords	Life Sciences, Biotechnology, Drug Discovery, Drug Development, Gmp-Grade Proteins, Mrna Manufacturing
Founded	2018
Employees	21-50
Socials

Key Contacts at KACTUS

Daniel Muller

Owner

Edmund Wang

Chief Executive Officer

Lei Yan

Director Of Business Development

KACTUS Email Formats

KACTUS uses 5 email formats. The most common is {first name}.{last name}@company.com (e.g., john.doe@company.com), used 45.6% of the time.

Format	Example	Percentage
{first name}.{last name}@company.com	john.doe@company.com	45.6%
{first name initial}{last name}@company.com	{first name initial}doe@company.com	22.3%
{first name}@company.com	john@company.com	15.1%
{first name}{last name}@company.com	johndoe@company.com	9.8%
{first name}_{last name}@company.com	john_doe@company.com	7.2%

About KACTUS

KACTUS is a biotechnology company serving global biopharma and diagnostics customers. We focus on commercial protein production for unmet needs in the drug development pipeline, including challenging recombinant proteins such as Claudin 18.2, MHC complexes, GPCR, CD20, and highly bioactive mRNA capping enzymes. Our goal is to deliver first-to-market innovative protein and antibody products. We also offer custom protein production including both research-grade and GMP-grade material. SAMS™ Technology Platform Our proprietary Structure Aided Design & Multiplex Screening (SAMS™) platform uses bioinformatics and 3D modeling to create vast search spaces for protein configurations. Expression conditions are optimized in vitro to identify settings that produce a natural protein configuration with bioactivity in multiple cell lines/settings. Quality KACTUS performs strict quality control testing on all our products including endotoxin levels. We also have facilities compatible with U.S. FDA cGMP guidelines to produce GMP-grade material. Our GMP-level partnerships are designed to provide you with routine bulk supply of material and supporting documentation to bring you from the R&D stage to commercial manufacturing and regulatory submission. In addition, our SAMS™ platform will assist in custom scientific optimization of your reagent.

KACTUS revenue & valuation

Annual revenue	$3,000,000
Revenue per employee	$112,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$9,600,000
Total funding	No funding